CrossrefInfokarte
Comment on ‘The potential impact of H1 antihistamines on clinical outcomes in NSCLC patients undergoing EGFR‐TKIs treatment’
British Journal of Clinical Pharmacology · 2026-11-11
DOI: 10.1002/bcp.70920 ↗Abstract
Kein Abstract verfügbar.
EUVIMED